Image Based Cytometry in Cell Analysis Market Size, Share, and Industry Analysis, By Product (Instruments, Consumables, and Software), By Application (Clinical and Research), By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Hospitals & Diagnostic Centers), and Regional Forecast, 2025-2032

The image based cytometry is a combination of high throughput flow cytometry with single cell image acquisition microscopy. Flow cytometry is a commonly used and effective method for analyzing the light scatter and fluorescence signals emitted by the cells labeled with specific markers to identify their characteristics. It is a widely used technique to analyze cells in clinical and preclinical settings.

The image based cytometry offers spatial information along with the fluorescence intensity of each channel for cell analysis. The multiple images generated on single cells enable the biomarker identification and information regarding the location and morphology of the marker. For instance, the ImageStream system by Cytek Biosciences can capture multiple fluorescent images at rates of up to 5,000 objects per second, which enables the accurate interpretation of results.

Currently, image based cytometry is highly used for research activities rather than clinical purposes. This can shift in the coming years as the application of these devices emerges in clinical settings.

Image based cytometry in the cell analysis market includes image flow cytometers, software, and consumables such as antibodies, staining agents, & others. The market is expected to grow significantly as it is a potential tool that combines a flow cytometer and microscope. Additionally, technological advancements are expected to drive market growth in the coming years.  

Additionally, the factors driving growth include the increased patient demand for precision medicine, industry investment, extensive R&D initiatives, rising regulatory approvals, and the introduction of futuristic products, services & bioinformatics tools.

• For instance, NanoCellect Biomedical Inc. received a USD 1.8 million Phase II Small Business Innovation Research (SBIR) grant to advance its imaging flow cytometry technology to sort cells through the utilization of artificial intelligence-derived features.

Furthermore, the market players’ strategic initiatives for the expansion of image-based cytometry are anticipated to propel the market growth in the coming years. However, the high cost, complexity of image analysis, and large sample volume with high cell numbers can potentially hamper the growth of the market.

In 2020, during the COVID-19 pandemic, the market witnessed negative growth due to the worldwide lockdown restrictions and limited usage of these devices for research and development activities. Later, in 2021, due to the lockdown relaxations, there was an increase in market growth as the demand for advanced techniques and tools increased across the globe. Additionally, the product launches and developments in image based cytometry further boosted the market growth.

Segmentation

Key Insights

The report covers the following key insights:

• Overview: Advancements & Emerging Applications of Imaging Flow Cytometers
• Key Industry Developments (Mergers, Partnerships, and Acquisitions)
• New Product Launches By Key Players
• Impact of COVID-19 on the Market

Analysis by Product

Based on product, the market is classified into instruments, consumables, and software. The instruments segment held a significant share of the market. The rising number of research and development activities to expand the applications of the image based flow cytometry is expected to augment the demand for these devices. Moreover, the increasing launches of new devices are expected to boost the market growth further.

• For instance, in June 2021, Thermo Fisher Scientific Inc. launched the Invitrogen Attune CytPix Flow Cytometer. It’s an imaging flow cytometer that combines a fluorescent flow cytometer with high-quality images.    

The software segment is anticipated to grow significantly over the projected years. The addition of new features in the software for high-definition images is expected to drive market growth in the near future. Moreover, the strategic collaborations between companies to develop advanced software is expected to drive segmental growth.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held a significant share in the global image based cytometry in the cell analysis market. The presence of major players such as Thermo Fisher Scientific Inc., Cytek Biosciences, Bio-Rad Laboratories, Inc., and huge R&D investments & initiatives for single cell studies for drug discovery and diagnostics are significant factors contributing to the growth of the region’s market. Additionally, a rising number of product launches and strategic acquisitions are anticipated to propel the market growth in the near future. Moreover, the rising prevalence of cancer in the region and the demand for accurate biomarker detection are expected to drive the region’s growth further.

• For instance, in February 2023, Cytek Biosciences acquired the Flow Cytometry and Imaging Business from DiaSorin to expand its imaging flow cytometry business.

The Asia Pacific market is expected to witness faster growth during the forecast period. The key growth factor includes industry-academic collaboration, and rising R&D activities in collaboration with the major players are anticipated to drive the region’s market growth. Additionally, the market expansion of key global players in the region is expected to propel the market growth in the near future.

• For instance, in March 2023, Singapore's A*STAR institute and BD collaborated to advance flow cytometry analysis, including image based cytometers for immunology research.

Key Players Covered

The report includes key players, such as Thermo Fisher Scientific Inc., Cytek Biosciences, Yokogawa Fluid Imaging Technologies, Inc., Revvity, Bio-Rad Laboratories, Inc., BD, ChemoMetec, and GE HealthCare.

Key Industry Developments

• In May 2023, BD (Becton, Dickinson, and Company) launched a FACSDiscover S8 Cell Sorter, an image based cytometer that combines BD SpectralFX Technology and BD CellView Image Technology for the real-time imaging of sorted cells to uncover more detailed information on cells which is not possible in traditional flow cytometry experiments.
• In September 2022, PerkinElmer launched the Cellaca PLX image cytometry system to streamline the research and manufacturing of cell and gene therapies.
• In April 2022, BD (Becton, Dickinson, and Company) introduced a new range of flow cytometry reagents, BD Horizon RealYellow 586 Reagents, which can be used for image based cytometry, for better detection and imaging.